Promoting and facilitating strategies to improve cardiovascular health worldwide
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
Webinars & e‑Learning
Specific training and best-practice modules, including ISCP on-demand webinars and ISCP-endorsed webinars
-
Expert Reviews & Analysis
Expert Reviews, Opinions and Brief Reports. Independent summary information to keep you up to date with the latest research.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists, scientists and medical practitioners.
ISCP Statement on the war in Ukraine The ISCP condemns the military aggression put forward by the leadership of the Russian Federation against Ukraine. With strong support from our colleagues, the ISCP urges for the aggression to cease and any conflict to be resolved on peaceful terms. The continued aggression against Ukraine by the leadership of the Russian Federation and Belarus has led the ISCP to temporarily exclude individuals based in the Russian Federation or in Belarus from active participation in any ISCP event or activity, including those being offered exclusively with a full membership. The ISCP very much regrets the effect this may have on physicians and allied healthcare professionals based in the Russian Federation and in Belarus. This should not be viewed as personal retaliation. However, the message to the leadership in these countries must be distinct and unequivocal.
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
Our first five webinars produced in collaboration with our partners Radcliffe Cardiology are now available to view in the Webinars On Demand section:
1- Ferric Carboxymaltose: Ironing Out the Issues Around Heart Failure-Related Readmissions,
2- Inclisiran: A Jab Goes a Long Way,
3- Edoxaban: ENGAGEing in Individualisation of DOACs,
4- Valsartan Sacubitril: Has our PARADIGM shifted?, and
5- Clopidogrel or Ticagrelor: Why, When, for Whom?
Details of future webinars are available in Upcoming webinars, including the next in our series on 8th March 2023: Nebivolol: No limb pain? – Details for registration to follow soon!
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Upcoming Events
27
Oct
24
Nov
23
Nov
8
Mar
Nebivolol: No limb pain?
A to Z of CV Pharmacotherapy, Webinar 08 Mar 2023
7
Dec
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
Using adult BP criteria may reclassify many adolescents as hypertensive
Posted on January 27, 2023
The use of the updated American Heart Association 2022 ambulatory BP monitoring guideline reclassified many adolescents from normotensive to hypertensive, researchers reported.An... more
Link between AF and mortality in severe aortic stenosis attenuated by LV function
Posted on January 27, 2023
Atrial fibrillation was associated with mortality in patients with significant aortic stenosis, but correction for left ventricular diastolic function rendered the association... more
Women widely underrepresented in stroke trial leadership
Posted on January 27, 2023
An analysis of hundreds of stroke trials shows significantly more men than women were registered as principal investigators from 2011 to 2020,... more
Post-TAVR strokes reported more frequently in comprehensive stroke centers
Posted on January 27, 2023
In a cohort of patients who had transcatheter aortic valve replacement at 22 hospitals in Michigan, post-TAVR stroke was more common at... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Alberto Lorenzatti
VP / President Elect
Affiliations/Memberships Founder and Past President of the Argentine Lipids Society (2003-2005); Current Chair of the Americas Federation from the International Atherosclerosis Society (IAS). Research Interests Atherosclerosis Lipid Metabolism Inflammation and CHD more
-
Pablo Avanzas
Secretary
Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more
-
Sang Hong Baek
President
Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more
-
Georg Noll
Treasurer
Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more